{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:28:49Z","timestamp":1725409729715},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,3]]},"DOI":"10.7759\/cureus.68570","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T22:20:15Z","timestamp":1725402015000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Treatment of Refractory Asthma Clinically Diagnosed As Eosinophilic Granulomatosis With Polyangiitis in a Hairdresser Using Tezepelumab"],"prefix":"10.7759","author":[{"given":"Toyoshi","family":"Yanagihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiyasu","family":"Igata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.41.1.42","article-title":"Occupational asthma in a hairdressing salon","volume":"41","author":"Blainey AD","year":"1986","unstructured":"Blainey AD, Ollier S, Cundell D, Smith RE, Davies RJ. Occupational asthma in a hairdressing salon. Thorax. 1986, 41:42-50. 10.1136\/thx.41.1.42","journal-title":"Thorax"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5271\/sjweh.361","article-title":"Occupational skin and respiratory diseases among hairdressers","volume":"24","author":"Leino T","year":"1998","unstructured":"Leino T, Tammilehto L, Hyt\u00f6nen M, Sala E, Paakkulainen H, Kanerva L. Occupational skin and respiratory diseases among hairdressers. Scand J Work Environ Health. 1998, 24:398-406. 10.5271\/sjweh.361","journal-title":"Scand J Work Environ Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.5.3590","article-title":"Occupational asthma and occupational rhinitis in hairdressers","volume":"128","author":"Moscato G","year":"2005","unstructured":"Moscato G, Pignatti P, Yacoub MR, Romano C, Spezia S, Perfetti L. Occupational asthma and occupational rhinitis in hairdressers. Chest. 2005, 128:3590-8. 10.1378\/chest.128.5.3590","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00420-022-01852-w","article-title":"Respiratory toxicity of persulphate salts and their adverse effects on airways in hairdressers: a systematic review","volume":"95","author":"Macan J","year":"2022","unstructured":"Macan J, Babi\u0107 \u017d, Hallmann S, et al.. Respiratory toxicity of persulphate salts and their adverse effects on airways in hairdressers: a systematic review. Int Arch Occup Environ Health. 2022, 95:1679-702. 10.1007\/s00420-022-01852-w","journal-title":"Int Arch Occup Environ Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12995-022-00351-5","article-title":"Respiratory afflictions during hairdressing jobs: case history and clinical evaluation of a large symptomatic case series","volume":"17","author":"Hiller J","year":"2022","unstructured":"Hiller J, Greiner A, Drexler H. Respiratory afflictions during hairdressing jobs: case history and clinical evaluation of a large symptomatic case series. J Occup Med Toxicol. 2022, 17:10. 10.1186\/s12995-022-00351-5","journal-title":"J Occup Med Toxicol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-00958-w","article-title":"Evidence-based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis","volume":"19","author":"Emmi G","year":"2023","unstructured":"Emmi G, Bettiol A, Gelain E, et al.. Evidence-based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis. Nat Rev Rheumatol. 2023, 19:378-93. 10.1038\/s41584-023-00958-w","journal-title":"Nat Rev Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2023-0079","article-title":"Tezepelumab: an anti-thymic stromal lymphopoietin monoclonal antibody for the treatment of asthma","volume":"15","author":"Shinkai M","year":"2023","unstructured":"Shinkai M, Yabuta T. Tezepelumab: an anti-thymic stromal lymphopoietin monoclonal antibody for the treatment of asthma. Immunotherapy. 2023, 15:1435-47. 10.2217\/imt-2023-0079","journal-title":"Immunotherapy"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00492-1","article-title":"Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study","volume":"11","author":"Menzies-Gow A","year":"2023","unstructured":"Menzies-Gow A, Wechsler ME, Brightling CE, et al.. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study. Lancet Respir Med. 2023, 11:425-38. 10.1016\/S2213-2600(22)00492-1","journal-title":"Lancet Respir Med"},{"key":"ref9","unstructured":"Japanese diagnostic criteria for EGPA. (2024). Accessed. 23 August 2024: https:\/\/www.nanbyou.or.jp\/entry\/3878."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.41982","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for Eosinophilic granulomatosis with polyangiitis","volume":"74","author":"Grayson PC","year":"2022","unstructured":"Grayson PC, Ponte C, Suppiah R, et al.. 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for Eosinophilic granulomatosis with polyangiitis. Arthritis Rheumatol. 2022, 74:386-92. 10.1002\/art.41982","journal-title":"Arthritis Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/ar4550","article-title":"Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study","volume":"16","author":"Sada KE","year":"2014","unstructured":"Sada KE, Yamamura M, Harigai M, et al.. Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther. 2014, 16:101. 10.1186\/ar4550","journal-title":"Arthritis Res Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/art.40205","article-title":"Adding azathioprine to remission-induction glucocorticoids for eosinophilic granulomatosis with polyangiitis (Churg-Strauss), microscopic polyangiitis, or polyarteritis nodosa without poor prognosis factors: a randomized, controlled trial","volume":"69","author":"Pu\u00e9chal X","year":"2017","unstructured":"Pu\u00e9chal X, Pagnoux C, Baron G, et al.. Adding azathioprine to remission-induction glucocorticoids for eosinophilic granulomatosis with polyangiitis (Churg-Strauss), microscopic polyangiitis, or polyarteritis nodosa without poor prognosis factors: a randomized, controlled trial. Arthritis Rheumatol. 2017, 69:2175-86. 10.1002\/art.40205","journal-title":"Arthritis Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.03.003","article-title":"Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials","volume":"43","author":"Samson M","year":"2013","unstructured":"Samson M, Pu\u00e9chal X, Devilliers H, et al.. Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials. J Autoimmun. 2013, 43:60-9. 10.1016\/j.jaut.2013.03.003","journal-title":"J Autoimmun"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler ME","year":"2017","unstructured":"Wechsler ME, Akuthota P, Jayne D, et al.. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl J Med. 2017, 376:1921-32. 10.1056\/NEJMoa1702079","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2311155","article-title":"Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis","volume":"390","author":"Wechsler ME","year":"2024","unstructured":"Wechsler ME, Nair P, Terrier B, et al.. Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis. N Engl J Med. 2024, 390:911-21. 10.1056\/NEJMoa2311155","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1341310","article-title":"Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis","volume":"11","author":"Desaintjean C","year":"2024","unstructured":"Desaintjean C, Ahmad K, Traclet J, et al.. Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis. Front Med (Lausanne). 2024, 11:1341310. 10.3389\/fmed.2024.1341310","journal-title":"Front Med (Lausanne)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12515-9","article-title":"Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status","volume":"10","author":"Lyons PA","year":"2019","unstructured":"Lyons PA, Peters JE, Alberici F, et al.. Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status. Nat Commun. 2019, 10:5120. 10.1038\/s41467-019-12515-9","journal-title":"Nat Commun"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-024-02888-x","article-title":"Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma","volume":"25","author":"Vincent-Galti\u00e9 N","year":"2024","unstructured":"Vincent-Galti\u00e9 N, Marquant Q, Catherinot E, Ackermann F, Magnan A, Tcherakian C, Groh M. Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma. Respir Res. 2024, 25:272. 10.1186\/s12931-024-02888-x","journal-title":"Respir Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/293277-successful-treatment-of-refractory-asthma-clinically-diagnosed-as-eosinophilic-granulomatosis-with-polyangiitis-in-a-hairdresser-using-tezepelumab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T22:20:17Z","timestamp":1725402017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/293277-successful-treatment-of-refractory-asthma-clinically-diagnosed-as-eosinophilic-granulomatosis-with-polyangiitis-in-a-hairdresser-using-tezepelumab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.68570","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,3]]}}}